Syndromic incidence of ovarian cancer after liver transplantation: Is breast cancer an antecedent risk?
✍ Scribed by Joseph F. Buell; E. Steve Woodle
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 52 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20026
No coin nor oath required. For personal study only.
✦ Synopsis
Ovarian cancer is the gynecologic malignancy with the highest number of deaths in the United States. Previous studies had found a decreased incidence of female gynecological malignancies after liver transplantation. In order to estimate the incidence of ovarian carcinoma after liver transplantation, we evaluated 1,708 consecutive liver transplant recipients from 1984 to 2001. Of them, 770 (43%) were female. Routine follow-ups were performed at 1, 2, 5, and 10 years after transplantation. There were two cases of ovarian carcinoma. Both occurred in recipients with a previous history of breast cancer. Based on these data, we conclude that the incidence of ovarian cancer is 1:385 among all female liver transplant recipients, and 1:6.5 among those with a history of pretransplant breast cancer. We recommend that regular checkups be undertaken, especially in the population at highest risk.